Using Video Images to Improve Advance Care Planning in Patients With Cancer
2 other identifiers
interventional
80
1 country
1
Brief Summary
The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 6, 2009
CompletedFirst Posted
Study publicly available on registry
September 2, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedMay 1, 2012
April 1, 2012
1.8 years
August 6, 2009
April 28, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
end of life preference at time of interview
5 minutes after survey
Secondary Outcomes (2)
knowledge
5 minutes after survey
decisional conflict
5 minutes after survey
Study Arms (1)
Cancer subjects
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Terminal, progressive cancer with poor prognosis whose treatment intent is palliative, based on the following definition:
- All patients with brain cancer, liver cancer, inoperable non-small cell lung carcinoma, pancreatic cancer, or gallbladder cancer; OR
- Patients with the following cancers: metastatic colon cancer or stage III or IV non-small cell lung cancer; OR
- Patients with the following cancers, if first-line therapy has failed and limited response is expected to second-line therapy: breast cancer, colorectal cancer, head and neck cancer, stomach cancer, esophageal cancer, melanoma, leukemia, ovarian cancer, prostate cancer, renal cancer, sarcoma, lung cancer, myeloma, or lymphoma.
- The terms terminal, progressive, poor prognosis, palliative intent and limited response will be judged by the patient's oncologist (and not by the RSA or consenting professional).
- Return patient visit (defined as a patient known to the oncologist from previous assessments and treatments, where the working and personal relationship has been established and not a new patient to the clinic).
- English speaking. Only English-speaking patients will be included in our present study since English is the validated language of our study tools.
- Given the sensitive nature of the study, clinicians will decide whether the patient is a potentially appropriate subject based on their knowledge of the patient.
- Able to provide informed consent.
- Age greater than or equal to 21.
You may not qualify if:
- MMSE \< 25.
- Psychological state not appropriate for end-of-life discussion as determined by the treating clinician.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Memorial Sloan Kettering
New York, New York, 10065, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Angelo E. Volandes, MD, MPH
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Faculty
Study Record Dates
First Submitted
August 6, 2009
First Posted
September 2, 2009
Study Start
August 1, 2009
Primary Completion
June 1, 2011
Study Completion
June 1, 2011
Last Updated
May 1, 2012
Record last verified: 2012-04